What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-12-28 compared with 2022-12-28 · 57 added, 44 removed, 3 unchanged (97% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Company’s Common Stock currently trades on the NASDAQ Capital Markets under the symbol “CETX.”

of December 23, 2022, the Company had 64 shareholders of record.

This amount does not take into account shareholders whose shares are

held in “street name” by brokerage houses or other intermediaries.

Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.001 and 50,000,000 shares of common stock, $0.001 par

value per share.

On December 23, 2022, there were 27,778,856 shares of common stock issued and outstanding, 2,183,463 shares of Series

1 preferred stock issued and 2,119,363 shares outstanding, and 50,000 shares of Series C preferred stock issued and outstanding.

reported by NASDAQ Capital Markets, on December 23, 2022, the closing sales price of the Company’s Common Stock was $0.10 per share.

board of directors declared a one-time cash dividend on our common stock in April 2017.

The terms of our series 1 preferred stock provide

for the payment of semiannual dividends on the last day of March and September in each year, which began in March 2017.

No other cash

dividends have been declared or paid by us on our stock during either of the two most recent fiscal years or the period through the date

of this prospectus.

Other than with respect to our series 1 preferred stock, our board of directors declares dividends when, in its discretion,

it determines that a dividend payment, as opposed to another use of cash, is in the best interests of the stockholders.

Such decisions

are based on the facts and circumstances then existing including, without limitation, our results of operations, financial condition,

contractual restrictions, restrictions imposed by applicable law and other factors our board of directors deems relevant.

we cannot predict when, or whether, another dividend on our common stock will be declared in the future.

Authorized for Issuance under Equity Compensation Plans

following table presents certain information as of September 30, 2022, regarding our equity compensation plans:

of Common Stock Shares to be Issued upon Exercise of Outstanding Options

Average Exercise Price of Outstanding Options

of Securities Remaining Available for Future Issuance under Plans (1)

MARKET FOR REGISTRANT’S COMMON EQUITY,

RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

The Company’s Common Stock

currently trades on the NASDAQ Capital Markets under the symbol “CETX.”

As of December 26, 2023, the Company

had 70 shareholders of record.

This amount does not take into account shareholders whose shares are held in “street name”

by brokerage houses or other intermediaries.

The Company is authorized to issue

10,000,000 shares of preferred stock, par value $0.001 and 50,000,000 shares of common stock, $0.001 par value per share.

26, 2023, there were 1,055,636 shares of common stock issued and outstanding, 2,408,053 shares of Series 1 preferred stock issued and

2,343,953 shares outstanding, and 50,000 shares of Series C preferred stock issued and outstanding.

As reported by NASDAQ Capital

Markets, on December 26, 2023, the closing sales price of the Company’s Common Stock was $5.40 per share.

Dividend Policy

Our board of directors declared

a one-time cash dividend on our common stock in April 2017.

The terms of our series 1 preferred stock provide for the payment of semiannual

dividends on the last day of March and September in each year, which began in March 2017.

No other cash dividends have been declared or

paid by us on our stock during either of the two most recent fiscal years or the period through the date of this Annual Report.

than with respect to our series 1 preferred stock, our board of directors declares dividends when, in its discretion, it determines that

a dividend payment, as opposed to another use of cash, is in the best interests of the stockholders.

Such decisions are based on the facts

and circumstances then existing including, without limitation, our results of operations, financial condition, contractual restrictions,

restrictions imposed by applicable law and other factors our board of directors deems relevant.

As a result, we cannot predict when, or

whether, another dividend on our common stock will be declared in the future.

Securities Authorized for Issuance under Equity Compensation Plans

The following table presents certain

information as of September 30, 2023, regarding our equity compensation plans:

Plan category

Number of Common Stock Shares to be Issued upon Exercise of Outstanding Options

Weighted Average Exercise Price of Outstanding Options

Number of Securities Remaining Available for Future Issuance under Plans (1)

Approved by security holders

Compensation Plan

2020 Equity Compensation Plan

Not approved by security holders

more detailed information regarding our equity compensation plans in the Notes to Consolidated Financial Statements in this 2022

Sales of Unregistered Securities

information set forth below relates to our issuances of securities without registration under the Securities Act of 1933 during the reporting

period which were not previously included in an Annual Report on Form 10-K, Quarterly Report on Form 10-Q or Current Report on Form 8-K.

the fiscal year ended September 30, 2022, 193,971 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series

1 Preferred Stock.

the fiscal year ended September 30, 2022, we issued 5,481,102 shares of common stock to satisfy $4,688,524 of notes payable and accumulated

December 16, 2022, 1,365,560 shares of common stock were issued to satisfy $200,000 of notes payable and accumulated interest.

securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder.

The holders represented

their intention to acquire the securities for investment only and not with a view towards distribution.

The investors were given adequate

information about us to make an informed investment decision.

See more detailed information regarding our equity compensation plans in the Notes to Consolidated Financial Statements in this Annual Report on Form 10-K for the year ended September 30,2023.

Recent Sales of Unregistered Securities

The information set forth below

relates to our issuances of securities without registration under the Securities Act of 1933 during the reporting period which were not

previously included in an Annual Report on Form 10-K, Quarterly Report on Form 10-Q or Current Report on Form 8-K.

For the fiscal year ended September

30, 2023, 213,894 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

For the fiscal year ended September

30, 2023, we issued 241,655 shares of common stock to satisfy $1,917,873 of notes payable and accumulated interest.

For the fiscal year ended September

30, 2023, we issued 30,103 shares of common stock in exchange for $215,800 of services to the Company.

On October 6, 2022, 115,037 shares

of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

These securities were issued pursuant

to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder.

The holders represented their intention to acquire the securities

for investment only and not with a view towards distribution.

The investors were given adequate information about us to make an informed

investment decision.

We did not engage in any general solicitation or advertising.

our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.

SELECTED FINANCIAL DATA

required under Regulation S-K for “smaller reporting companies

We directed our transfer agent to issue the stock certificates

with the appropriate restrictive legend affixed to the restricted stock.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity